ATRA - Atara Biotherapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 51.85B
Enterprise Value 31.49B
Trailing P/E N/A
Forward P/E 1-7.30
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)4.58
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-7.91

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Sep 30, 2018


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-35.51%
Return on Equity (ttm)-61.08%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -188.53M
Net Income Avi to Common (ttm)-186M
Diluted EPS (ttm)-4.65
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)364.54M
Total Cash Per Share (mrq)7.99
Total Debt (mrq)10.3M
Total Debt/Equity (mrq)2.56
Current Ratio (mrq)13.81
Book Value Per Share (mrq)8.83

Cash Flow Statement

Operating Cash Flow (ttm)-147.29M
Levered Free Cash Flow (ttm)-119.92M

Trading Information

Stock Price History

Beta (3Y Monthly) 3.39
52-Week Change 3-11.99%
S&P500 52-Week Change 31.08%
52 Week High 354.45
52 Week Low 327.85
50-Day Moving Average 336.07
200-Day Moving Average 337.52

Share Statistics

Avg Vol (3 month) 3502.32k
Avg Vol (10 day) 3269.95k
Shares Outstanding 545.65M
Float 32.32M
% Held by Insiders 16.82%
% Held by Institutions 1110.48%
Shares Short (Jan 31, 2019) 46.43M
Short Ratio (Jan 31, 2019) 410.61
Short % of Float (Jan 31, 2019) 423.16%
Short % of Shares Outstanding (Jan 31, 2019) 414.09%
Shares Short (prior month Dec 31, 2018) 46.56M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A